AIDS: Safety, regulation and the law in procedures using blood and blood products

Medicine, Science and the Law

Volumn 37, Issue 3, 1997, Pages 215-227

  Craven, B M ^a   Stewart, G T ^b   Khan, M ^c  

^a NORTHUMBRIA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NORTHUMBRIA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD TRANSFUSION; BLOODBORNE BACTERIUM; EUROPE; FEMALE; HEALTH CARE AND PUBLIC HEALTH; HEMOPHILIA A; HUMAN; HUMAN RIGHTS; LEGAL APPROACH; LEGAL ASPECT; MALE; SOCIAL BEHAVIOR; STANDARD; UNITED KINGDOM; UNITED STATES;

HEALTH CARE AND PUBLIC HEALTH; LEGAL APPROACH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; EUROPE; FEMALE; GREAT BRITAIN; HEMOPHILIA A; HUMAN RIGHTS; HUMANS; MALE; SOCIAL RESPONSIBILITY; UNITED STATES;

EID: 0031179817     PISSN: 00258024     EISSN: None     Source Type: Journal    
DOI: 10.1177/002580249703700306     Document Type: Article

References (69)

1. Ablin R. (1985) Transglutaminase: co-factor in aetiology of AIDS? Lancet 1, 813-14.
2. Adams J. (1989) AIDS: The HIV Myth. London, Macmillan.
3. AIDS-Haemophilia French Study Group (1985) Immunologic and Virologic Studies of Multi-transfused Patients: the role of type and origin of blood products. Blood 66, 896-901.
4. Aronson D. L. (1983) Pneumonia deaths in haemophiliacs. Lancet II, 1023.
5. Aronson D. L. (1988) Cause of death in haemophilia patients in the United States from 1968 to 1979. Am. J. Haemophilia 27, 7-12.
6. Balfe P., Simmonds P., Ludlam P., Bishop J. O. and Leigh Brown A. J. (1990) Concurrent evolution of HIV1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J. Virology, 64, 6221-33.
7. Beral V., Peterman T. A., Berkelman R. L. and Jaffe H. W. (1990) Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet, (335).
8. Brahams D. (1987) AIDS and the law. Medico-Legal Journal 55, 191-7.
9. Carr R., Veitch S. E., Edmond E., Peutherer J. F., Prescott R. J., Steel C. M. and Ludlam C. A. (1984) Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population. Lancet 1, 431-4.
10. Cohen H., Mackie I. J., Anagnostopoulos N., Savage G. F. and Machin S. J. (1989) Lupus anticoagulant, anticardiolipin antibodies, and human immunodeficiency virus in haemophilia. J. Clin. Path. 42, 629-33.
11. Concorde Coordinating Committee (1994) MRC/ANRS trandomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 343, 871-81.
12. Consensus Conference (1988) Perioperative red blood cell transfusion', J. Am. Med. Assoc. 260, 700-3.
13. Cooper M. H. and Culyer A. J. (1968) The Price of Blood. Institute of Economic Affairs, Hobart Paper No. 41.
14. Corey L. C. and Holmes K. K. (1980) Sexual transmission of Hepatitis A in homosexual men: incidence and mechanism. New Engl. J. Med. 302, 435.
15. Courouce A., Muller A. and Richard B. (1986) False positive Western Blot reactions to HIV-1 in blood donors. Lancet, 2, 921-2.
16. Craven B. M, Stewart G. T. and Taghavi M. (1994) Amateurs confronting politicians: a case study of AIDS in England. J. Public Policy 13, 305-25.
17. Craven B. M. and Stewart G. T. (1995) Corporate governance, financial reporting, regulation and the AIDS threat in Scotland. Financial Accountability and Management 11, 223-41.
18. de Biasi R., Rocino A., Miraglia E., Mastrullo L. and Quirino A. A. (1991) The impact of a very high purity Factor VIII concentrate on the immune system of human immunodeficiency virus-infected haemophiliacs: a randomised prospective, two-year comparison with an intermediate purity concentrate. Blood 78 (8), 1990-22,
19. Dietzman D. E., Harnisch J. P. and Ray C. G. et al. (1977) Hepatitis B surface antigen (HBsAG) and antibody to HGsAG: prevalence in homosexual and heterosexual males. J. Am. Med. Assoc. 238, 2625.
20. Doe v. United States of America (1990), Medical Law Review pp.131.
21. Drew W. L., Mintz L., Miner R. C., Sands M. and Ketterer B. (1981) Prevalence of cytomegalovirus infection in homosexual men J. Infectious Diseases 143, 188-92.
22. Drug and Therapeutics Bulletin (1997) 35, 23-30.
23. Dufort B. (1991) French doctors accused of HIV in blood. Bulletin of Medical Ethics 74, 13-15.
24. Financial Times (1991) French insurers step in with AIDS cash. 10 December.
25. Financial Times (1992a) Waldegrave announces HIV compensation. 18 February.
26. Financial Times (1992b) France puts officials on trial over use of HIV-infected blood. 23 June.
27. Financial Times (1993) Kouchner urges AIDS testing. 25 January.
28. Financial Times (1994a) Through gas and high water. 30 May.
29. Financial Times (1994b) French ex-premier under investigation over AIDS. 1 October.
30. Gibbons J. Cory J. M., Hewlett I. K., Epstein J. H. and Eyster M. E. (1990) Silent infections with human immunodeficiency virus type 1 are highly unlikely in multitransfused sero-negative haemophiliacs. Blood 76, 1924-26.
31. Goedert J. J., Cohen A. R., Kessler C. M., Eichinger S., Seremetis S. V., Rabkin C. S., Yellin F. J., Rosenberg P. S. and Aledort L. M. (1994) Risks of immunodeficiency, AIDS, and death related to purity of Factor VIII concentrate. Lancet 344, 791-2.
32. Harris D. and Haigh R. (1990) AIDS: A Guide to the Law. Tavistock Routledge.
33. Johnson H. G. (1967) Are you worth your weight in gold? J. Political Economy 75, 205-7.
34. Jones-Lee M. W. (1976) The Value of Life. London, Martin Robertson.
35. Kay J. (1988) The economics of regulation. In: Seldon, A. (ed.) Financial Regulation or Over-Regulation? London, Institute of Economic Affairs, pp.17-31.
36. Lancet (1994) J-P Allain: last chapter, or merely latest? Editorial 344, 487-8.
37. Ludlam C. A., Tucker J. and Steel C. M. (1985) HTLV3 infection (HIV) in seronegative haemophiliacs after transfusion of Factor VIII. Lancet 1, 233-6.
38. Lundberg G. D. (1988) Serological diagnosis of HIV infection by Western Blot testing. J. Am. Med. Assoc. 260, 674-9.
39. Madhok R., Gracie J. A., Smith J., Lowe G. D. O. and Forbes C. D. (1990) Capacity to produce interlukin 2 is impaired in haemophilia in the absence and presence of HIV 1 infection. British J. Haematology 76, 70-4.
40. Medical Law Reports (1992), Medical Law Alert 3, Pt. 9.
41. Medical Law Reports (1993), Medical Law Alert 4, Pt. 7.
42. Medical Law Reports (1994), Medical Law Alert 5, Pt. 1.
43. Medical Law Review (1994), p. 110.
44. Meyer K. B. and Panker S. G. (1987) Screening for HIV; can we afford the false positive rate? New Engl. J. Med. 317, 238-41.
45. Midthun K., Garrison G., Clements M. L., Farzadegan H., Fernie B and Quinn T. (1990) Frequency of indeterminant Western Blot tests in healthy adults at low risk for HIV infection. J. Infectious Diseases 162, 1379-82.
46. Mooney G. H. (1977) The Valuation of Human Life. London and Basingstoke, Macmillan.
47. Morgan J. (1993) As they say in Europe: the sex therapist and the shopping trolley. Financial Times, 16 January.
48. Mortimer P. (1991) The fallibility of Western Blot. Lancet 337, 286-7.
49. Nau J-Y (1994) New debate in French blood saga. Lancet 344, 398.
50. North R. (1992) Death by Regulation: the butchery of the British meat industry. Institute of Economic Affairs Health and Welfare Unit, Health Series, No. 12.
51. Passaleva A., Massai G., Morfini M., Longo G., Rossi Ferrini P. L. and Ricci M. (1983) Circulating immune complexes in haemophilia and von Willebrand's disease. Scandinavian J. Haematology 31, 466-74.
52. PHLS (1995) Public Health Laboratory Service, Official Surveillance, UK, September.
53. Posner R. A. (1974) Theories of economic regulation. Bell J. Economics and Management Sci. 5, 335-8.
54. Root-Bernstein R. S. (1993) Rethinking AIDS. New York, Free Press.
55. Rumi M. G., Columbo M., Romeo R., Colucci G., Gringeri A. and Mannucci P. M. (1990) Serum hepatitis B virus DNA detects cryptic hepatitis B virus infections in multitransfused hemophilic patients. Blood 75, 1654-8.
56. Seldon A. (ed.) (1988) Financial Regulation or Over-Regulation? Institute of Economic Affairs.
57. Seremetis S., Aledort L. M. and Sacks H. (1990) Differential effects on CD4 counts of high or intermediate purity Factor VIII concentrates in HIV+ haemophiliacs. Blood and Coagulation Abstracts III, 76, 46a, 1455.
58. Sharp D. (1994) L' affaire Allain. Lancet, 344, 467.
59. Stewart G. T. (1995) Epidemiology and transmission of AIDS. Genetica 95, 173-93.
60. Stigler G. J. (1971) The theory of economic regulation. Bell J. Economics and Management Sci. 2, 3-21.
61. Surgenor D., Wallace E. L., Hao S. H. and Chapman R. H. (1990) Collection and transfusion of blood in the United States 1982-1988 New Engl. J. Med. 322, 23.
62. Tabor E. (1984) Review of transmission of hepatitis by clotting factor concentrates. Scandinavian J. Haematology Suppl. 40, No. 33, 303-8.
63. The Times (1989) Judge refuses HIV sufferer access to blood donor's name. 22 December.
64. The Times (1997) HIV victims awarded $670m. 8 May.
65. Tower G. (1993) A public accountability model of accounting regulation. Bri. Accounting Review 25, 61-85.
66. Veljanovski C. (1991) Regulators and the Market. London, Institute of Economic Affairs.
67. Wall J. (1994) Blood and blunder. Medico-Legal Journal 62, 161-3.
68. Ward J. W., Bush T. J., Perkins H. A., Lieb L. E., Allen J. R., Goldfinger D., Samson S. M., Pepkowitz S. H., Fernanda L. P., Holland P. V., Kleinman S. H., Grindon A. J., Garner J. L., Rutherford G. W. and Holmberg S. D. (1989) The natural history of transfusion-associated infection with human immuno- deficiency virus. New Engl. J. Med. 321 (14), 947-52.
69. Webster A., Lee C. A., Cook D. G., Grundy J. E., Emery V. C., Kernoff P. B. and Griffiths P. D. (1989) Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immune deficiency virus infection. Lancet 2, 63-6.